Sofwave names Optimedic main distributor in Spain

What changed

Optimedic now carries Sofwave's technology in the national market. The stated goal is to get the device in front of more new centers and specialized practices. Optimedic's commercial experience and sector knowledge are the reason given for the pairing.

The article names four clinics already using the system: Maribel Yébenes in Madrid, Dr. Helena Delso in Zaragoza, Dr. Virginia Benítez in Marbella, and Dr. Vilella in Soria. It describes them as reference centers. It does not say how long each has used the device or how many units are in place.

Carolina Gay Sorrius, founder and managing director of Optimedic, framed the deal around clinic needs. "Bringing a technology to clinics requires understanding their needs and supporting professionals in their incorporation into daily practice," she said. That is the sentence a distributor would say, and it is also the one an owner should test in the first sales call.

The device is a synchronized parallel-beam ultrasound system, which Sofwave calls SUPERB. The company says it acts on the mid-dermis and that the energy supports collagen and elastin production and hyaluronic acid renewal. Those are mechanism claims. The article says Sofwave has published clinical studies and holds international regulatory authorizations for specific indications, and that how it talks about those uses must match the documentation in each market.

What it means for practices

Analysis: a distributor change in a single country usually matters most to the clinics that sit outside the existing referral networks. If Optimedic is building new accounts rather than inheriting old ones, expect more demo days and training slots over the next year. That is the lever a practice owner can use.

The article also cites a perception report from the Spanish Society of Aesthetic Medicine, presented in April 2026 and prepared by Sigma Dos. It says 46% of Spanish adults have had some beauty treatment, and that more than 70% name whole-body health and controlled aging among their goals. Those numbers come from a trade survey, and the article does not give the sample size or method. Use them as market color, not as a forecast for your own patient volume.

What owners can do

Ask the distributor for the indication list in writing, tied to the Spanish labeling for the exact handpiece you would buy. Do not accept the mechanism language from a brochure as a substitute.

Ask who trains your staff, how many hours, and whether the training is on your site or at a vendor event. The article does not say.

Ask for the warranty and service terms and who handles them: Sofwave, Optimedic, or a third party. The article is silent on both.

Ask for the reference clinics' contact details and call at least two of the four named above. A reference center that is happy to talk costs the distributor nothing to provide.

What we don't know yet

The article gives no price, no financing terms, no unit count, and no exclusivity terms. It does not say whether Optimedic replaces an earlier Spanish distributor or whether this is the first. It does not say what share of Sofwave's sales Spain represents.

Portugal appears in the headline, but the text mentions only a Portuguese congress in Estoril in September. It does not name a Portuguese distributor. Owners there should ask who holds the account.

The next public event is the AECEP Meeting 2026, held November 19 to 21 in Madrid, where Optimedic will show the system with Sofwave. That is the place to see the device and ask the questions the press release skips.

Business information, not medical or legal advice. Verify regulatory status at FDA.gov.